A citation-based method for searching scientific literature

Vanita R Aroda, Robert Ratner. J Clin Endocrinol Metab 2008
Times Cited: 41







List of co-cited articles
153 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
William C Knowler, Elizabeth Barrett-Connor, Sarah E Fowler, Richard F Hamman, John M Lachin, Elizabeth A Walker, David M Nathan. N Engl J Med 2002
31

Impaired fasting glucose and impaired glucose tolerance: implications for care.
David M Nathan, Mayer B Davidson, Ralph A DeFronzo, Robert J Heine, Robert R Henry, Richard Pratley, Bernard Zinman. Diabetes Care 2007
856
24

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
J Tuomilehto, J Lindström, J G Eriksson, T T Valle, H Hämäläinen, P Ilanne-Parikka, S Keinänen-Kiukaanniemi, M Laakso, A Louheranta, M Rastas,[...]. N Engl J Med 2001
21




Follow-up report on the diagnosis of diabetes mellitus.
Saul Genuth, K G M M Alberti, Peter Bennett, John Buse, Ralph Defronzo, Richard Kahn, John Kitzmiller, William C Knowler, Harold Lebovitz, Ake Lernmark,[...]. Diabetes Care 2003
12

Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies.
Hertzel C Gerstein, Pasqualina Santaguida, Parminder Raina, Katherine M Morrison, Cynthia Balion, Dereck Hunt, Hossein Yazdi, Lynda Booker. Diabetes Res Clin Pract 2007
342
12

Prediabetes: a position statement from the Australian Diabetes Society and Australian Diabetes Educators Association.
Stephen M Twigg, Maarten C Kamp, Timothy M Davis, Elizabeth K Neylon, Jeffrey R Flack. Med J Aust 2007
92
12

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.
Jean-Louis Chiasson, Robert G Josse, Ramon Gomis, Markolf Hanefeld, Avraham Karasik, Markku Laakso. Lancet 2002
12





Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis.
M I Harris, R Klein, T A Welborn, M W Knuiman. Diabetes Care 1992
913
9



Prediabetes: a high-risk state for diabetes development.
Adam G Tabák, Christian Herder, Wolfgang Rathmann, Eric J Brunner, Mika Kivimäki. Lancet 2012
9

Impaired fasting glucose: how low should it go?
J E Shaw, P Z Zimmet, A M Hodge, M de Courten, G K Dowse, P Chitson, J Tuomilehto, K G Alberti. Diabetes Care 2000
104
7

Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
D R Matthews, J P Hosker, A S Rudenski, B A Naylor, D F Treacher, R C Turner. Diabetologia 1985
7


Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study.
F de Vegt, J M Dekker, A Jager, E Hienkens, P J Kostense, C D Stehouwer, G Nijpels, L M Bouter, R J Heine. JAMA 2001
433
7


Diet, lifestyle, and the risk of type 2 diabetes mellitus in women.
F B Hu, J E Manson, M J Stampfer, G Colditz, S Liu, C G Solomon, W C Willett. N Engl J Med 2001
7

Cardiovascular morbidity and mortality associated with the metabolic syndrome.
B Isomaa, P Almgren, T Tuomi, B Forsén, K Lahti, M Nissén, M R Taskinen, L Groop. Diabetes Care 2001
7


Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited.
M M Engelgau, T J Thompson, W H Herman, J P Boyle, R E Aubert, S J Kenny, A Badran, E S Sous, M A Ali. Diabetes Care 1997
254
7

Actos Now for the prevention of diabetes (ACT NOW) study.
Ralph A Defronzo, Maryann Banerji, George A Bray, Thomas A Buchanan, Stephen Clement, Robert R Henry, Abbas E Kitabchi, Sunder Mudaliar, Nicolas Musi, Robert Ratner,[...]. BMC Endocr Disord 2009
51
7

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.
X R Pan, G W Li, Y H Hu, J X Wang, W Y Yang, Z X An, Z X Hu, J Lin, J Z Xiao, H B Cao,[...]. Diabetes Care 1997
7

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
William C Knowler, Sarah E Fowler, Richard F Hamman, Costas A Christophi, Heather J Hoffman, Anne T Brenneman, Janet O Brown-Friday, Ronald Goldberg, Elizabeth Venditti, David M Nathan. Lancet 2009
7

Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence.
Earl S Ford, Guixiang Zhao, Chaoyang Li. J Am Coll Cardiol 2010
322
7





Forty-five year follow-up after uninephrectomy.
D M Narkun-Burgess, C R Nolan, J E Norman, W F Page, P L Miller, T W Meyer. Kidney Int 1993
158
4

Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius?
J E Shaw, P Z Zimmet, M de Courten, G K Dowse, P Chitson, H Gareeboo, F Hemraj, D Fareed, J Tuomilehto, K G Alberti. Diabetes Care 1999
237
4

Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002.
Catherine C Cowie, Keith F Rust, Danita D Byrd-Holt, Mark S Eberhardt, Katherine M Flegal, Michael M Engelgau, Sharon H Saydah, Desmond E Williams, Linda S Geiss, Edward W Gregg. Diabetes Care 2006
918
4


Glycemic status and development of kidney disease: the Framingham Heart Study.
Caroline S Fox, Martin G Larson, Eric P Leip, James B Meigs, Peter W F Wilson, Daniel Levy. Diabetes Care 2005
146
4

No evidence of accelerated loss of kidney function in living kidney donors: results from a cross-sectional follow-up.
I Fehrman-Ekholm, F Dunér, B Brink, G Tydén, C G Elinder. Transplantation 2001
211
4

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.
Sarah Wild, Gojka Roglic, Anders Green, Richard Sicree, Hilary King. Diabetes Care 2004
4

The prevention of type 2 diabetes.
Jill P Crandall, William C Knowler, Steven E Kahn, David Marrero, Jose C Florez, George A Bray, Steven M Haffner, Mary Hoskin, David M Nathan. Nat Clin Pract Endocrinol Metab 2008
147
4

Normal fasting plasma glucose and risk of type 2 diabetes diagnosis.
Gregory A Nichols, Teresa A Hillier, Jonathan B Brown. Am J Med 2008
95
4

Normal fasting plasma glucose levels and type 2 diabetes in young men.
Amir Tirosh, Iris Shai, Dorit Tekes-Manova, Eran Israeli, David Pereg, Tzippora Shochat, Ilan Kochba, Assaf Rudich. N Engl J Med 2005
331
4

Blood glucose concentrations < or = 125 mg/dl and coronary heart disease risk.
Byron J Hoogwerf, Dennis L Sprecher, Gregory L Pearce, Monica Acevedo, Joseph P Frolkis, JoAnne Micale Foody, Jean A Cross, Fredric J Pashkow, Killian Robinson, Donald G Vidt. Am J Cardiol 2002
17
11

"Normal" blood glucose and coronary risk.
E Barrett-Connor, D L Wingard. BMJ 2001
21
9


Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose.
Q Qiao, K Pyörälä, M Pyörälä, A Nissinen, J Lindström, R Tilvis, J Tuomilehto. Eur Heart J 2002
126
4

Lowering the criterion for impaired fasting glucose will not provide clinical benefit.
Mayer B Davidson, Pamela B Landsman, Charles M Alexander. Diabetes Care 2003
64
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.